are then retrieved by clathrin-mediated endocytosis and recycled via early endosomes
. Munc13-1 Immunoreactivity in the Hippocampus (A) Low-power view of the layer-specific distribution. L, stratum lucidum; O, stratum oriens; R, stratum radiatum; LM, stratum lacunosum-moleculare; M, molecular layer of dentate gyrus; H, Hilus of dentate gyrus. Arrow head, hippocampal fissure; arrows, border between inner and outer two-thirds of the molecular layer. Scale bar, 1 mm. (B) In region CA3, the pyramidal cell layer (P) is unstained whereas the stratum lucidum (L) shows intensely stained patches of the same size and distribution as mossy fiber terminals. Scale bar, 50 m. (C) In region CA1, the cell bodies in the pyramidal cell layer (P) are unstained. In the stratum radiatum, there is a punctate pattern suggestive of presynaptic elements lining the surface of dendrites (arrows). Scale bar, 50 m. (D) A mossy fiber terminal (star) in stratum lucidum shows heterogeneous distribution of reaction product that appears densest close to the presynaptic membrane. Arrowheads point to active zones from the dendritic side. Scale bar, 0.5 m.
(E) Numerous Munc13-1-positive small axon terminals in stratum radiatum of region CA1, same symbols as in (D) . Scale bar, 0.5 m.
isoforms, Munc13-2 and Munc13-3, are brain-specific target that represents a second messenger pathway alternative to PKC. mammalian homologs of the C. elegans unc-13 gene product (Brose et al., 1995) . Like their nematode counterpart, Munc13s are thought to regulate synaptic funcResults tion. Munc13-1 interacts with syntaxin 1, an essential component of the synaptic release machinery involved Localization of Munc13-1 in Rat Brain All Munc13 isoforms are expressed in a brain-specific in vesicle maturation and fusion (Betz et al., 1997) , and with DOC2, a putative regulator of transmitter secretion manner (Brose et al., 1995) . However, their subcellular localization, or that of their C. elegans counterpart (Orita et al., 1997) . Beyond such fragmentary circumstantial evidence, the functional role of Munc13s (or that unc-13p, is not known. As morphological data on the localization of Munc13s are essential for further funcof unc-13p) in synaptic physiology is not known.
In the present study, we provide direct evidence for tional analysis, we studied the distribution of Munc13-1 in rat brain. For that purpose, a novel monoclonal antian involvement of Munc13-1 in presynaptic signaling. Our findings characterize Munc13-1 as a high-affinity body to Munc13-1 (clone 3H5) was generated and used in a detailed immunocytochemical analysis of rat hippophorbol ester receptor that is specifically localized to presynaptic transmitter release sites. Phorbol ester bindcampus and cortex. In hippocampus, a distinct layering of Munc13-1 iming leads to the translocation of all Munc13 isoforms to the plasma membrane of transfected fibroblasts. Upon munostaining was observed. While layers containing pyramidal and granule cell bodies were devoid of signal, presynaptic overexpression in Xenopus laevis neuromuscular junctions, Munc13-1 acts as a phorbol esterthe degree of staining in the neuropil coincided with the layered distribution of termination areas of the different dependent enhancer of spontaneous and evoked neurotransmitter release. Our data establish Munc13-1 as an hippocampal axon systems ( Figure 1A ). Strongest signals were detectable in regions of highest presynaptic important presynaptic phorbol ester and diacylglycerol terminal density. In particular, strong patchy staining of Phorbol Ester Binding to Munc13-1 Our immunocytochemical analysis strongly suggested mossy fiber terminals in stratum lucidum ( Figure 1B ) and punctate staining of presynaptic terminals in stratum a presynaptic function of Munc13-1. In view of the possibility that unc-13p-like proteins might indeed serve as radiatum ( Figure 1C ) were observed. Electron microscopic analysis demonstrated that most presynaptic presynaptic diacylglycerol and phorbol ester receptors, we analyzed phorbol ester binding to Munc13-1 using boutons in the stratum radiatum were strongly stained ( Figure 1E ), whereas very little or no labeling of dendrites a recombinant bacterial fusion protein encoding glutathione-S-transferase (GST) in frame with the Munc13-1 or dendritic spines was apparent. Likewise, all mossy fiber terminals in the stratum lucidum contained high C1-domain (Munc13-1C1 WT ; Figure 3A ). The C1-domain contains a Cys 6 His 2 motif that forms a zinc finger strucamounts of Munc13-1 immunoreactivity that was concentrated at presynaptic release sites adjacent to postture (Hommel et al., 1994) and is responsible for phorbol ester binding in PKCs. The first His residue in the synaptic densities ( Figure 1D ).
Like in the hippocampus, a prominent and dense punCys6His2 motif (corresponding to His-567 in Munc13-1) is essential for phorbol ester binding in PKCs (Hommel ctate labeling in the neuropil, along with unstained pyramidal cell bodies in all cortical layers, indicated a preet al., 1994; Quest et al., 1994) . Munc13-1C 1 WT bound the protein kinase C activator dominantly presynaptic localization of Munc13-1 in the cerebral cortex (Figure 2A Figure 2C ). Quantification of immunostained synapses in randomly chosen 4A), indicating that the integrity of the zinc finger domain is essential for phorbol ester binding. The affinity of the micrographs demonstrated that only 45% of synapses in the parietal cortex are Munc13-1-positive (in contrast Munc13-1 C 1 -domain for [ 3 H]4␤-PDBu was found to be similar to that of PKC (KD ϭ 5 nM; Figures 4B and 4C) . to 96% in the stratum lucidum and 56% in the stratum radiatum of the hippocampus). As a distinct cortical Likewise, the pharmacological characteristics of phorbol ester binding to the Munc13-1 C1-domain closely specialty, spots of Munc13-1 immunoreactivity were occasionally detected in apical dendrites of pyramidal resembled those observed in PKC. Binding was inhibited by the putative endogenous ligand diacylglycerol cells where the reaction product was mostly confined to the vicinity of vesicular structures ( Figure 2D ). This ( Figure 4D ), by 4␤ phorbol esters like 4␤-PDBu and 4␤-12-O-tetradecanoylphorbol-13-acetate (4␤-TPA), and dendritic labeling contributed less than 10% to the overall Munc13-1 immunoreactivity in the cortical neuropil, by calphostin C, which all bind to the C 1 -domain of PKCs as well. In addition, the rather nonspecific PKC inhibitor as estimated from randomly chosen electron micrographs, while essentially all other stained structures repolymyxin B inhibited phorbol ester binding to Munc13-1. In contrast, commonly used control reagents that do sembled presynaptic terminals.
In all brain regions, staining was abolished after prenot activate PKC (the 4␣ phorbol esters 4␣-PDBu and 4␣-TPA), and reagents that bind to the ATP binding adsorption of the antibody to a Sepharose column coupled with the antigen used for immunization (data not site of PKC (bisindolylmaleimide), did not inhibit phorbol ester binding to the Munc13-1 C 1 -domain ( Figure 4E ; shown). 
in Synaptic Transmission
Our morphological, biochemical, and cell biological to the plasma membrane (Newton, 1995 (Newton, , 1997 Sakai et al., 1997) . To assay whether a similar phorbol esteranalyses established Munc13-1 as a presynaptic highaffinity diacylglycerol and phorbol ester receptor. To dependent translocation and activation of Munc13 takes place in a cellular environment, we studied the redistrievaluate a possible contribution of Munc13-1 to the diacylglycerol-or phorbol ester-dependent modulation of bution of transiently expressed Munc13 constructs in response to phorbol esters in a human fibroblast cell presynaptic efficacy, we examined the consequences of Munc13-1 overexpression in Xenopus neuromuscular line (HEK293). For that purpose, we generated a series of mammalian expression constructs that encode fusion junctions.
For that purpose, we injected mRNA encoding fullproteins of full-length Munc13-1, Ϫ2, or Ϫ3 with C-terminally attached green fluorescent protein (GFP; Figure  length Munc13-1 WT or Munc13-1 H567K (which carries the His-567 to Lys mutation and does not bind phorbol es-3A). HEK293 cells were transfected with these constructs and challenged with 100 nM 4␤-TPA. We found ters) together with GFP mRNA into early blastomeres of Xenopus and studied synaptic transmission in nervethat all three wild-type Munc13 isoforms translocated to the plasma membrane in response to 4␤-TPA (Figure muscle cocultures prepared from the neural tube and associated myotomal tissue of injected stage 20-22 em-5). In contrast, full-length Munc13-1 H567K (which carries the His-567Lys mutation and does not bind phorbol esbryos. In each case, identical heterologous expression levels of Munc13-1 WT and Munc13-1 H567K were verified ters) was insensitive to 4␤-TPA ( Figure 5 ), indicating that phorbol esters mediate the translocation of Munc13 by Western blotting of individual injected and uninjected embryos from batches that were also used for coculture proteins in a PKC-independent manner by binding to the Munc13 C 1 -domains.
preparations (data not shown). Trains of six action potentials were elicited every 2-4 seconds in nerve cells To determine the minimal sequence of Munc13-1 that is required to mediate translocation, we expressed GFP by extracellular stimulation with a monopolar electrode or by current injection through the patch pipette in the fusion proteins of Munc13-1 fragments ( Figure 3A ). As translocation of PKC is dependent on both the C 1 -current clamp mode. The resulting evoked postsynaptic currents (EPSCs) were recorded from the innervated domain and the C 2 -domain, we first tested the phorbol ester-induced redistribution of the C1/C2 tandem domain muscle cells in the whole-cell configuration. After about 100 sec, 200 nM 4␤-TPA was applied locally for 60 sec of Munc13-1 (Munc13-1C1/C2 WT ) and found that it translocated to the plasma membrane after stimulation with onto the area of nerve-muscle contact.
In a typical uninjected cell ( Figure 7A ), the EPSC ampli-4␤-TPA, whereas the distribution of the corresponding His-567Lys mutation (Munc13-1C1/C2 H567K ) was unaftude increased sharply approximately 20 sec after the start of 4␤-TPA application and reached its maximum fected ( Figure 6 ). In contrast, translocation of Munc13-1C 1 /C 2 WT as well as full-length Munc13-1 WT was not inafter about 30 sec. Averaging the EPSC amplitude before and after application of 4␤-TPA revealed an induced by Ca 2ϩ ionophores (data not shown), supporting previous biochemical findings (Brose et al., 1995) and crease in the absolute EPSC amplitudes from 5.7 Ϯ 1.8 nA to 8.5 Ϯ 1.2 nA (mean Ϯ s.d.), which corresponds to a indicating that, unlike PKC, the C 2 -domain of Munc13-1 does not induce Ca 2ϩ -dependent membrane associa-48% increase in relative synaptic transmission following phorbol ester application. Analysis of 19 noninjected tion. Rather, a single copy of a C 1 -domain zinc finger is cells demonstrated an average EPSC amplitude increase of 44.6 Ϯ 4.5% (mean Ϯ s.e.m.) after 4␤-TPA application.
When the same protocol was applied to neuromuscular junctions of nerve cells overexpressing Munc13-1 WT (as identified by GFP fluorescence), we observed a strong increase in the responsiveness of synapses to phorbol esters. In the example illustrated in Figure 7B , local application of 200 nM 4␤-TPA increased the average EPSC amplitude by 95% (7.7 Ϯ 1.4 nA to 15 Ϯ 3.1 nA; mean Ϯ s.d.). Following a fast initial rise within the first 10 sec after 4␤-TPA application, the amplitude reached a plateau after approximately 60 sec. Analysis of 13 Munc13-1 WT -injected cells demonstrated an average increase of 82.1 Ϯ 12.9% (mean Ϯ s.e.m.) in relative synaptic transmission following 4␤-TPA application, compared to about 45% in control cells that did not express Munc13-1. This difference was statistically significant as determined by t-test (p Ͻ 0.05).
To demonstrate that the observed increase in relative synaptic transmission following Munc13-1 WT expression and phorbol ester stimulation is independent of PKC and exclusively due to phorbol ester binding by Munc13-1, we overexpressed Munc13-1 H567K in Xenopus embryos and analyzed synaptic transmission in the resulting neuromuscular junctions in culture. The His-567 to Lys mutation in Munc13-1 H567K abolishes phorbol ester binding to the Munc13-1 C 1 -domain and prevents its phorbol ester-induced translocation to the plasma membrane (Figures 4, 5, and 6). Likewise, phorbol ester stimulation of synaptic transmission in neuromuscular junctions overexpressing Munc13-1 H567K was indistinguishable from that of uninjected control synapses ( Figure 7C ), although expression levels of Munc13-1 H567K were identical to those obtained for Munc13-1 WT (data not shown). Application of 200 nM 4␤-TPA resulted in an average increase in relative transmitter release of 50% ( Figure  7C ), which was almost identical to that observed in control cells. Analysis of 11 Munc13-1 H567K -injected cells demonstrated an average increase of 42.1 Ϯ 5.1% (mean Ϯ s.e.m.) in relative synaptic transmission following 4␤-TPA application, compared to about 45% in control cells that did not express Munc13-1 and 82.1 Ϯ 12.9% in cells expressing Munc13-1 WT ( Figure 7D ). These data suggest that activation of the Munc13-1 C1-domain (His-567 to Lys mutation in the C 1 -domain, abolishing phorbol ester binding) with C-terminally attached GFP. Cells were either incubated in the presence of 100 nM 4␤-TPA or kept under control conditions (no TPA), and the subcellular localization of expressed proteins was analyzed with a BioRad MRC 1024 confocal laser scanning microscope. Note that all wild-type Munc13 isoforms translocate to the plasma membrane in response to phorbol ester, whereas the phorbol ester insensitive full-length mutant Munc13-1 H567K does not.
variation (which reflect the variability of EPSC ampliof 1-3 sec immediately after the end of the last EPSC in a six pulse train and compared their frequency and tudes) were slightly smaller in Munc13-1-and Munc13-1 H567K -expressing neurons as compared to control cells.
amplitudes. Figure 8 depicts examples of SSCs collected immediately after the train in the absence or presThese differences in basal synaptic transmission may indicate an increased quantal content in overexpressing ence of 4␤-TPA. The average frequency for control cells was 1.6 Hz before 4␤-TPA application and increased to cells (Table 1) . However, the significance of this observation needs to be reexamined in a different experimental 2.4 Hz after 4␤-TPA application ( Figures 8A and 8B ). Munc13-1-injected cells exhibited an average SSC paradigm because an unequivocal interpretation of quantitative data is difficult in the Xenopus system that frequency of 3.8 Hz before 4␤-TPA treatment, approximately 2.5 times higher than that of control cells. Followis characterized by a rather high variability of absolute ampitudes between cells/preparations.
ing 4␤-TPA application, the frequency increased to 7.2 Hz in Munc13-1-injected cells (Figures 8A and 8B) . In An EPSC is often followed by a phase of asynchronous release that most likely reflects the increased release contrast, the SSC frequency in cells expressing the mutant Munc13-1 H567K was not significantly elevated (Figprobability of single vesicles due to elevated calcium (Rahamimoff and Yaari, 1973) . We recorded these as ures 8A and 8B). Average SSC amplitudes were slightly smaller in Munc13-1-and Munc13-1 H567K -expressing cells "spontaneous synaptic currents" (SSCs) for a duration as compared to control cultures (Table 1) . These results present study, we provide direct evidence for an involvement of Munc13 proteins in presynaptic function. indicate that Munc13-1 also enhances the asynchronous release of synaptic vesicles by a mechanism that is largely dependent on the presence of an intact Munc13-1 Is a Presynaptic Protein C 1 -domain.
Previous attempts to determine the precise localization of Munc13 proteins failed due to the poor specificity of the available antibodies in immunocytochemistry (Brose Discussion et al., 1995; Betz et al., 1997) . For that reason, we generated a new isoform-specific monoclonal antibody to Several indirect lines of evidence have identified Munc13 proteins as possible regulators of synaptic transmission:
Munc13-1 (see Experimental Procedures) that was used to demonstrate an almost exclusively presynaptic lo-(1) Mutations in their C. elegans counterpart unc-13p lead to a paralyzed phenotype characterized by accucalization of Munc13-1 (Figures 1 and 2 ). Our findings demonstrate that a first prerequisite supporting pubmulation of neurotransmitter and resistance to acetylcholine esterase inhibitors, suggesting a deficit in translished conjectural claims of a presynaptic function of Munc13-1 and unc-13p, namely its appropriate localizamitter release in these mutants (Hosono et al., 1987; Hosono and Kamiya, 1991) ; (2) the primary structures tion, is indeed met.
Munc13-1 appears to be concentrated at synaptic of Munc13 and unc-13 proteins contain C1-and C2-domains, indicating a regulation of Munc13/unc-13p active zones. In the large hippocampal mossy fiber terminals, Munc13-1 immunoreactivity was most promifunction by diacylglycerol and calcium (Maruyama and Brenner, 1991; Ahmed et al., 1992; Kazanietz et al., nent in presynaptic subcompartments that were opposite of postsynaptic densities (Figure 1 ). Given the 1995); (3) Munc13-1 interacts with syntaxin 1, a component of the synaptic release machinery involved in synlimited diffusibility of the dye reaction product generated with our immunodetection method, these data suggest aptic vesicle priming and fusion (Betz et al., 1997) ; and (4) Munc13-1 interacts with DOC2, a putative regulator that Munc13-1 is concentrated at presynaptic release sites and not distributed uniformly in the presynaptic of transmitter release, and influences DOC2-stimulated exocytosis from PC12 cells (Orita et al., 1997) . In the cytosol. Support for this view is provided by biochemical observed in parietal cortex (55% of all observed terminals) and, to a lesser extent, in the stratum radiatum of the hippocamus (44% of all observed terminals). These percentages represent maximum values because limited antibody penetration contributes significantly to the number of unstained structures. However, our observations indicate that a significant number of synapses in cortex and hippocampus do not contain Munc13-1. We assume that these synapses contain Munc13-2 as in situ hybridization data demonstrate (I. A. and N. B., unpublished data) that Munc13-1 and Munc13-2 but not Munc13-3 are coexpressed in cortex and hippocampus of the rat. The only exception to the presynaptic localization of Munc13-1 was observed in cerebral cortex. Here, about 10% of all Munc13-1-positive structures were localized in dendrites. In most cases, the Munc13-1 immunoreactivity was confined to the vicinity of vesicular structures ( Figure 2D ). It is possible that these postsynaptic Munc13-1-containing structures represent dendritic release sites (Piotte et al., 1985; Chazal and Ohara, 1986; Pucak and Grace, 1994) .
Munc13 Proteins Are Phorbol Ester Receptors
The C1-domains of the three known Munc13 isoforms are extremely homologous and contain all critical residues necessary for phorbol ester binding in PKCs (Kazanietz et al., 1994) . Of the 51 residues that comprise the core Cys6His2 motif of the C1-domain zinc finger, only two are different between the isoforms: Munc13-1 Ile-590 is replaced by Leu in Munc13-2 and Munc13-1 Thr-598 is (Betz et al., 1996) . Because of this high homology, we 1991; Ahmed et al., 1992; Kazanietz et al., 1995) . We ishes binding completely ( Figures 3B and 4A ), demonstrating that the integrity of the C1-domain zinc finger is essential for phorbol ester binding. analyses that demonstrated that Munc13-1 is largely insoluble, most likely associated with components of In addition, the pharmacological characteristics of phorbol ester binding to Munc13-1 closely resemble the the synaptic cytoskeleton, but not present on synaptic vesicles (Brose et al., 1995; Betz et al., 1997) . However, inhibitor profile described for PKC C 1 -domains (Gordge and Ryves, 1994). Most importantly, diacylglycerol, an an unequivocal determination of Munc13-1 localization within the presynaptic terminal can only be achieved endogenous ligand for PKC C 1 -domains, inhibits binding to the Munc13-1 C 1 -domain with a potency comparable with preembedding immunogold methods, which have so far been unsuccessful with our antibody.
to that observed in PKC (Sharkey et al., 1984) . Also, calphostin C, the most potent and most frequently used Multiple Munc13-1-negative presynaptic terminals were C1-domain antagonist, and the typically used PKC-acti- (Figures 5 and 6 ). This effect is abolished in a Munc13-1 mutant that is unable to bind phorbol ester (Munc13-vating 4␤ phorbol esters, inhibit binding ( Figure 4E ). In contrast, 4␣ phorbol esters ( Figure 4E ), which are often 1 H567K ; Figures 5 and 6 ). It can therefore not be dependent on PKC or a neuron-specific binding partner but must applied as inactive control reagents in PKC experiments, and C2-ceramide, a possible endogenous ligand of C 1 -occur in response to a direct action of phorbol esters on the Munc13 C 1 -domain. In certain PKC and synaptodomains (data not shown), do not bind to the Munc13-1 C 1 -domain.
tagmin isoforms, membrane translocation or membrane binding can also be mediated by Ca 2ϩ /phospholipid These observations establish Munc13 proteins as novel phorbol ester targets whose most likely endogebinding to the regulatory C 2 -domains (Brose et al., 1992; Davletov and Sü dhof, 1993; Newton, 1995 Newton, , 1997 ; Sakai nous ligand is diacylglycerol. Our data imply that among the typically used control reagents in phorbol ester exet al., 1997). However, increasing the intracellular Ca 2ϩ concentration by addition of a Ca 2ϩ ionophore did not periments on PKC (C1-domain antagonists like calphostin C, inactive 4␣ phorbol esters, inhibitors of ATP bindinduce membrane translocation of full-length Munc13 isoforms or of Munc13-1 fragments containing the cening like bisindolylmaleimide), only potent and selective inhibitors of ATP binding to PKC would allow one to tral C2-domain (data not shown). These data strongly suggest that ligand binding to the distinguish phorbol ester-mediated effects on PKC from those on Munc13 proteins (assuming that Munc13s do Munc13 C 1 -domains has direct structural and functional consequences in a cellular environment. They result in not bind these ligands with a binding site outside the C 1 -domain). In the past, a large number of studies ina subcellular redistribution and membrane association of Munc13 proteins that may regulate an as yet unidentivestigating phorbol ester-mediated effects on PKC used control conditions that are inadequate in the light of the fied enzymatic activity. In contrast, Munc13 C 2 -domains may not function in Ca 2ϩ /phospholipid signaling and present findings (i.e., C 1 -domain antagonists or inactive 4␣ phorbol esters; see Gordge and Ryves, 1994 , for a Ca 2ϩ -dependent membrane association. Translocation of Munc13 isoforms in the synapse is recent review). Given the fact that ubiquitous Munc13 isoforms exist (GenBank entry AF020202; I. A., A. B., likely to be modulated by additional mechanisms. In rat brain, Munc13-1 and Ϫ3 are largely insoluble (Brose et and N. B., unpublished data), conclusions drawn from those studies would have to be reevaluated for a possial., 1995; I. A., A. B., and N. B., unpublished data) . Munc13-1 is specifically targeted to presynaptic acble involvement of Munc13 proteins if direct, PKC-independent effects of phorbol esters on these novel targets tive zones (Figures 1 and 2 ) by an unknown mechanism that may involve cytoskeletal components (Brose et al., were demonstrated. 1995, unpublished data) . Consequently, a diacylglyceroldependent membrane association/dissociation cycle Phorbol Ester-Mediated Regulation of Munc13 Proteins Is Direct and Independent of PKC of Munc13-1 must take place in the microenvironment of the presynaptic release site. In contrast, rat brain Membrane translocation of PKCs in response to phorbol esters is a well established phenomenon (Newton, 1995, Munc13-2 is mostly soluble (I. A., A. B., and N. B., unpublished data), and translocation in response to diacylglyc-1997; Sakai et al., 1997) . Phorbol esters bind to the C 1 -domain of PKCs and serve as hydrophobic anchors that erol is likely to produce more profound changes in the overall distribution of the protein. recruit the enzyme to the plasma membrane, stabilize its active conformation, and increase its susceptibility to other second messengers (Newton, 1995 (Newton, , 1997 . In
Munc13-1 Is a Phorbol Ester-Dependent Enhancer of Transmitter Release order to investigate whether phorbol ester binding to Munc13 isoforms indeed has structural and functional Our morphological, biochemical, and cell biological observations (Figures 1-6 ) suggest a role for Munc13-1 as a consequences for these proteins, we studied the effects of phorbol ester treatment on the subcellular distribution second messenger-dependent regulator of presynaptic function. To determine if Munc13-1 alters neurotransmitter of Munc13-1, -2, and -3 isoforms that were C-terminally tagged with GFP. secretion in response to phorbol esters, we overexpressed full-length Munc13-1 WT and the phorbol esterAll three Munc13 isoforms, as well as the isolated Munc13-1 C 1 -domain, translocate to the plasma meminsensitive mutant Munc13-1 H567K in Xenopus neuromuscular cocultures and analyzed the electrophysiological brane of HEK293 cells in response to phorbol esters has several advantages over other experimental paradigms. Proteins are expressed by the endogenous Xenopus protein synthesis machinery following injection of the respective mRNAs. This allows the expression of very large proteins, such as Munc13-1, which could otherwise not be synthesized in amounts sufficient for protein injection or that are too large for diffusion-based application through a patch pipette. Furthermore, generation and analysis of mutations are simple because sequence manipulations are performed on the cDNA level. Clearly defined mRNA constructs and their mutants can be introduced, allowing the design of optimal control conditions (point mutations, etc.). Finally, deleterious effects that may be associated with direct injections of peptides or proteins into presynaptic terminals are circumvented. The major disadvantage of the Xenopus neuromuscular coculture system is the fact that recorded responses can vary by a factor of 20 (0.5-10 nA, depending on the preparation/synapse examined), making a reliable quantitative analysis of absolute amplitude values almost impossible. We therefore concentrated in our analysis of Munc13-1 and Munc13-1 H567K overexpression on the relative effects of phorbol esters on transmitter release. Xenopus neuromuscular cocultures were used in the past to overexpress synapsin IIa (Schaeffer et al., 1994) , synaptophysin (Alder et al., 1995) , and frequenin (Olafsson et al., 1995) .
When Munc13-1 WT mRNA is injected into Xenopus embryos, the resulting neuromuscular synapses show a higher susceptibility to phorbol esters than untreated junctions (Figure 7 ). This gain-of-function effect of Munc13-1 WT is specific for the overexpressed protein, dependent on an intact C 1 -domain, and independent of PKC, as it is not observed when the phorbol esterinsensitive mutant Munc13-1 H567K is expressed at comparable levels (Figure 7) .
A similar C 1 -domain-dependent activity of Munc13-1 is also apparent on the level of SSCs following trains of these findings, a detailed study of the role of Munc13-1 in basal synaptic release has to be performed in a differcharacteristics of overexpressing synapses after phorent experimental paradigm. bol ester treatment.
In principle, the observed changes in synaptic transWith respect to the question addressed in the present mission due to Munc13-1 overexpression can be explained by (1) an effect of the protein on the structure study, the Xenopus heterologous expression system NaCl, and 0.5% ZnCl2. Thereafter, the animals were again perfused of synapses (e.g., the number of release sites per synwith 0.9% NaCl for 7 min to limit effects of postfixation. Brains were apse), or by (2) an increased release-ready vesicle pool immediately dissected and cryoprotected with 30% sucrose. On a after Munc13-1 expression, or by (3) an effect of Munc13-1 frozen microtome, 40 m thick sections were cut for light and elecon the release probability. Our data do not allow us to tron microcopic immunocytochemistry. The methods employed determine unequivocally the level at which Munc13-1 have been previously detailed (Rickmann and Wolff, 1995) . In brief, after blocking unspecific antibody binding, anti-Munc13-1 monoacts in the synaptic vesicle cycle. The fact that Munc13-1 clonal antibodies (clone 3H5) in ascites fluid were diluted 1:250 and overexpression does not alter paired pulse facilitation applied for 12-16 hr at 37ЊC. These were detected with the ABC or the coefficient of variation suggests that the protein method (Vector Laboratories) followed by a histochemical nickeldoes not affect release probability (Table 1) interacts directly with the exocytotic core complex by When a monoclonal antibody is used for immunostaining, the main binding to syntaxin (Betz et al., 1997) , with DOC2 (Orita sources of crossreactivity or artefactual staining are nonspecific et al., 1997) , and with components of the cytoskeleton antibodies and contaminating proteins in the ascites fluid. Therefore, (Brose et al., 1995, unpublished data) . It is possible that control experiments were performed with (1) anti-Munc13-1 monoclonal antibody ascites fluid that had previously been preadsorbed these interactors recruit Munc13-1 to docked vesicles to a Sepharose column coupled with the antigen used to generate at the active zone. There, it would be activated by diacylthe antibody and (2) 
Expression of Recombinant Proteins

Conclusion
Bacterial expression vectors encoding GST in frame with the Munc13-1 is a high-affinity phorbol ester and diacylglyc-
WT and Munc13-1C1 H567K ; residues erol receptor localized in the presynaptic terminal. It 556-651 of GenBank Acc. No. U24070) were generated in pGEXrepresents a novel, PKC-independent target of the diac-KG using PCR fragments (Figure 3 ). Proteins were expressed and ylglycerol second messenger pathway. Activation of purified as described (Guan and Dixon, 1991 Smith, 1989; Fabbri et al., 1994; Redman et al., 1997) .
in pEGFP-N1 (Clontech) using a combination of previously published
The presence of Munc13-1 as a functional diacylglycerol cDNA fragments (Brose et al., 1995; GenBank Acc. No. U24070, U24071, and U24072) and engineered PCR fragments that ensured and phorbol ester target at the active zone of the prereading frame conservation (Figure 3) . Constructs encoding the synaptic terminal allows direct access for diacylglyMunc13-1 C1/C2 tandem domain with a GFP sequence attached at cerol second messengers to the transmitter release maits C terminus (Munc13-1C1/C2 WT and Munc13-1C1/C2 H567K ; residues chinery, thereby adding a novel regulatory process to were generated in pcDNA3-GFP (pcDNA3 from Invitrogen our understanding of synaptic transmission. Ubiquitous with EGFP insert) using PCR fragments that carried engineered Kozak consensus sequences and starter ATGs at the 5Ј ends ( Figure   Munc13 isoforms may exert related functions in other 3). The construct encoding the Munc13-1 C1-domain with an tissues and cell types.
N-terminally attached GFP sequence (Munc13-1C1; residues 522-651 allowing a larger distance between GFP and the C 1-domain) was Experimental Procedures generated in pEGFP-C2 (Invitrogen) using a PCR fragment (Figure 3) . The His-567 to Lys mutations were introduced by PCR (see above).
Generation of Monoclonal Antibodies to Munc13-1
Munc13-1 vectors for use in Xenopus embryo expression experi-A monoclonal antibody to Munc13-1 was generated in collaboration ments (Munc13-1 WT and Munc13-1 H567K ) were generated in pCS2 ϩ with BioGenes (Berlin) using a fusion protein antigen encoding GST (Rupp et al., 1994) using inserts from a previously published fullin frame with residues 1399-1736 of Munc13-1 (pGEX-Munc13-1F; length Munc13-1 cDNA (Brose et al., 1995) . The His-567 to Lys Betz et al., 1997) . The monoclonal antibody (clone 3H5) detects a mutation was generated by replacement of part of the wild-type single band of 200 kDa in Western blots of brain membranes and sequence with a mutated cDNA fragment. HEK293 cells transfected with pcDNA-Munc13-1 (Brose et al., 1995) , All PCR-based constructs were verified by dideoxy chain terminawhich expresses full-length Munc13-1 (data not shown).
tion sequencing with dye terminators on an Applied Biosystems 373 DNA sequencer (Applied Biosystems). HEK293 cells were transImmunocytochemistry fected with the above constructs using the calcium phosphate coAdult, female Sprague-Dawley rats were anesthetized with ether precipitation method (Chen and Okayama, 1987 Amersham) to recombinant glutathione-S-transferase fusion proteins was measured according to Sharkey and Blumberg (1985) . perfused for 7 min that consisted of 4% unbuffered formalin, 0.9% [ 3 H]4␤-PDBu (10 nM) was incorporated into liposomes (20% phos-(Laemmli, 1970; Towbin et al., 1979; Brose et al., 1993) , and immunoreactive bands were visualized by enhanced chemoluminescence phatidylserine, 80% phosphatidylcholine, 300 g/ml final concentra-(ECL; Amersham). tion in assay; Avanti Polar Lipids) before addition to the assay.
Both Munc13-1 and Munc13-1 H567K were readily detectable at simiFor that purpose, chloroform solutions of phosphatidylserine and lar levels in 2-and 3-day-old embryos (data not shown), indicating phosphatidylcholine were evaporated under a stream of nitrogen.
the presence of the proteins at times when electrophysiological Dried lipids were resuspended in 50 mM Tris-HCl (pH 7.4) and 1 measurements were performed. Likewise, GFP fluorescence was mM EGTA and sonicated for 40 sec with a Braun Labsonic U tip detected for several days after injection. As expected, noninjected sonicator (Braun). Liposomes were centrifuged for 45 min at 3000 ϫ embryos showed no rat Munc13-1 immunoreactivity. gmax to remove aggregates and kept on ice until use. press Munc13-1 or Munc13-1 H567K , respectively. Synaptic currents were performed using the same procedure. Depending on the experwere recorded from innervated muscle cells in the whole-cell configiment, 0.3-3 g protein were used per assay. Each data point repreuration using a combination of EPC-9 and EPC-7 amplifiers driven sents the average of duplicate ([ 3 H]4␤-PDBu binding to wild-type by the Pulse v8.06 software package (Heka Elektronik). The pipette and mutated C 1 -domain) or triplicate (other experiments) determinasolution for the muscle cells contained 107 mM CsCl, 1 mM MgCl2, tions. Each experiment was performed at least twice with essentially 1 mM NaCl, 10 mM EGTA, and 10 mM HEPES (pH 7.3). The bath identical results.
solution contained normal frog ringer (NFR, 116 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , and 5 mM HEPES [pH 7.3]). The muscle cells were routinely clamped at Ϫ50 mV holding potential.
Translocation Assays
A 10 ms test pulse to Ϫ60 mV was given before each EPSC sweep HEK293 cells were grown on glass coverslips coated with 0.5% to estimate the series resistance for later offline series resistance gelatine (Schnittler et al., 1993) and transfected with GFP expression compensation as previously described (Rettig et al., 1997) . Action vectors 2 days prior to the experiment. The media was changed potentials were routinely elicited upon external stimulation (0.3-0.5 before the experiment, and 4␤-TPA (Sigma) was added from an ms, 0.2-2 A) on the nerve cell soma with frequencies of 0.5 Hz. aceton stock solution directly to the cell culture (100 nM final conAlternatively, the whole-cell configuration was established on the centration). Cells were incubated for 5-60 min at 37ЊC, washed twice soma of the nerve cell, and the nerve cell was held at a potential with phosphate-buffered saline, and fixed with 3% paraformaldebetween Ϫ50 and Ϫ70 mV in the current clamp mode. In current hyde in phosphate-buffered saline. Cover slips were mounted onto clamp mode, trains of six action potentials with an interval of 25 slides with Fluoromount-G (Southern Biotechnology Associates) msec were elicited every 4 sec with 2 ms current injections of 900 and observed with a MRC 1024 confocal laser scanning microscope pA. The pipette was filled with 114 mM K-gluconate, 10 mM KCl, 1 (BioRad).
mM NaCl, 1 mM MgCl 2 , 2 mM MgATP, 0.3 mM GTP, 50 M fura-2, and 10 mM HEPES (pH 7.3). Amplitudes of EPSCs were analyzed with locally written software in IGOR (WaveMetrix, Inc.) as previously Preparation of Nerve-Muscle Cocultures described (Rettig et al., 1997) . No significant correlation was found Xenopus nerve-muscle cocultures were prepared from the neural between the initial amplitude and the effect of 4␤-TPA. Spontaneous tube and associated myotomal tissue of stage 20-22 embryos as synaptic currents were recorded for a duration of 1-3 sec in experidescribed (Tabti and Poo, 1991; Rettig et al., 1997) . Following dissoments that were performed in the current clamp mode. SSC ampliciation in Ca 2ϩ Mg 2ϩ -free solution (125 mM NaCl, 2 mM KCl, 1.2 tudes and frequency were analyzed with locally written software in mM EDTA, and 5 mM HEPES [pH 7.6]), cells were plated on glass IGOR (WaveMetrix, Inc.). The inactive phorbol ester 4␣-PDBu did coverslips pretreated for about 60 min with ECL (entactin, collagen not affect any of the cells tested (data not shown). Since we found and laminin; Upstate Biotechnologies) and grown for about 24 hr at no apparent differences in either SSC frequency or phorbol ester 22ЊC. The culture medium consisted of 70% Leibovitz L-15 suppleeffect on EPSC amplitudes from Munc13-1-positive and Munc13-1-mented with GMS-X, antibiotics (Life Technologies), and BDNF (Alanegative muscle cells, the data were grouped regardless of whether mone Labs). All electrophysiological experiments were carried out muscles cells were expressing Munc13-1 or Munc13-1 H567K or no 1-2 days after plating.
exogenous protein (as judged by GFP coexpression).
